SCHOTT Pharma AG & Co. KGaA Stock
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.08 EUR | -0.75% | -3.87% | -12.80% |
May. 28 | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
May. 21 | Deutsche Bank Research lowers target for Schott Pharma - 'Buy' | DP |
Sales 2024 * | 976M 1.06B | Sales 2025 * | 1.1B 1.19B | Capitalization | 4.41B 4.79B |
---|---|---|---|---|---|
Net income 2024 * | 144M 156M | Net income 2025 * | 167M 181M | EV / Sales 2024 * | 4.72 x |
Net Debt 2024 * | 200M 218M | Net Debt 2025 * | 188M 204M | EV / Sales 2025 * | 4.18 x |
P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
26.6
x | Employees | 4,687 |
Yield 2024 * |
0.53% | Yield 2025 * |
0.62% | Free-Float | 19.7% |
1 day | +3.14% | ||
1 week | -3.87% | ||
1 month | -22.28% | ||
3 months | -25.63% | ||
6 months | +1.74% | ||
Current year | -12.80% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 23-04-03 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 23-04-03 |
Chairman | 59 | 23-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 29.3 | +2.81% | 166 058 |
24-05-30 | 28.5 | -0.14% | 76,594 |
24-05-29 | 28.54 | -5.56% | 64,659 |
24-05-28 | 30.22 | -1.31% | 42,486 |
24-05-27 | 30.62 | +0.46% | 18,265 |
Delayed Quote Xetra, May 31, 2024 at 11:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.80% | 4.79B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- 1SXP Stock